Zobrazeno 1 - 3
of 3
pro vyhledávání: '"C H, Ottensmeier"'
Autor:
M. Hardy-Werbin, O. Arpí, A. Taus, P. Rocha, D. Joseph-Pietras, L. Nolan, S. Danson, R. Griffiths, M. Lopez-Botet, A. Rovira, J. Albanell, C. H. Ottensmeier, E. Arriola
Publikováno v:
OncoImmunology, Vol 7, Iss 2 (2018)
Small-cell lung cancer (SCLC) is often associated with paraneoplastic syndromes. To assess the role of anti-neuronal autoantibodies (NAAs) as biomarkers of treatment outcome, we assessed NAAs in serial samples from SCLC patients treated with chemoimm
Externí odkaz:
https://doaj.org/article/9ad5a13990de4ec08c46aa95e70e2132
The classification of B cell tumors has relevance for refining and improving clinical strategies. However, consensus has been difficult to establish, and although a scheme is now available, objective criteria are desirable. Genetic technology will un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c7877aebb0e7d59bb0f05ea76240c4de
http://hdl.handle.net/11365/26796
http://hdl.handle.net/11365/26796
Autor:
C H, Ottensmeier, F K, Stevenson
Publikováno v:
Blood. 96(7)
Primary diffuse large B-cell lymphomas (DLBCLs) are aggressive tumors accounting for approximately 40% of B-cell malignancies. The immunoglobulin (Ig) variable region genes have undergone rearrangement and are commonly somatically mutated. The majori
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dff0cd910d87fe22e6c05d94b931da88
https://pubmed.ncbi.nlm.nih.gov/11001910
https://pubmed.ncbi.nlm.nih.gov/11001910